Esteban Cvitkovic

Researcher Next ID · RN-024958

Researcher · Biochemistry, Genetics and Molecular Biology

Paris, Slovenia

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Protein Degradation and Inhibitors

Cancer Treatment and Pharmacology

Head and Neck Cancer Studies

Colorectal Cancer Treatments and Studies

Multiple Myeloma Research and Treatments

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
Clinical Cancer Research · 2015 · https://doi.org/10.1158/1078-0432.ccr-14-1561
Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients
Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2004.05.210
Cellular and molecular pharmacology of oxaliplatin.
PubMed · 2002
Phase II Study of Oxaliplatin, Fluorouracil, and Folinic Acid in Locally Advanced or Metastatic Gastric Cancer Patients
Journal of Clinical Oncology · 2002 · https://doi.org/10.1200/jco.2002.02.021
Oxaliplatin: A review of preclinical and clinical studies
Annals of Oncology · 1998 · https://doi.org/10.1023/a:1008213732429
High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresis
Cancer · 1977 · https://doi.org/10.1002/1097-0142(197704)39:4<1372::aid-cncr2820390404>3.0.co;2-j
The renal pathology in clinical trials of Cis-platinum (II) diamminedichloride
Cancer · 1977 · https://doi.org/10.1002/1097-0142(197704)39:4<1362::aid-cncr2820390403>3.0.co;2-n

No projects listed.